Showing 1,981 - 2,000 results of 5,293 for search 'significantly ((((less decrease) OR (((greater decrease) OR (mean decrease))))) OR (nn decrease))', query time: 0.40s Refine Results
  1. 1981
  2. 1982
  3. 1983
  4. 1984
  5. 1985
  6. 1986
  7. 1987
  8. 1988
  9. 1989

    Baseline characteristics. by Daniela Sánchez-Santiesteban (21192342)

    Published 2025
    “…</p><p>Results</p><p>The cohort included 1,913 formal employees (mean age: 49.9 years), with 660 deaths (34.5%) recorded over the follow-up period. …”
  10. 1990
  11. 1991

    Package alternatives for deli meat. by Monireh Mahmoudi (21989413)

    Published 2025
    “…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …”
  12. 1992

    The study timeline. by Monireh Mahmoudi (21989413)

    Published 2025
    “…<div><p>Consumer food waste remains a significant concern in the United States, where approximately 40% of food goes uneaten, leading to major economic and environmental consequences. …”
  13. 1993
  14. 1994

    a, Anti-correlation of gene expression between <i>dmdR1</i> and its predicted regulon. Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875.... by Hannah E. Augustijn (10773096)

    Published 2025
    “…Left: Pearson correlation coefficients (PCCs) between <i>dmdR1</i> and all genes with a DmdR1 position weight matrix (PWM) score greater than 15 in their regulatory region. The vertical dashed line marks the refined PWM score threshold of 22.875. …”
  15. 1995

    Summary of study eligibility criteria. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  16. 1996

    Summary of study participation and feasibility. by Biban Gill (1473337)

    Published 2025
    “…Considering the high prevalence of BV among African, Caribbean and Black (ACB) women, we conducted a prospective, randomized, open-label phase 1 clinical trial to determine the feasibility, safety and tolerability of administering low-dose estrogen, probiotics or both in combination to improve vaginal health and decrease HIV-1 susceptibility.</p><p>Methods</p><p>ACB women aged 18–49 from the Greater Toronto Area (GTA) were randomized to one of four study arms: intravaginal estradiol (Estring©; 7.5mg/day); a vaginal probiotic (RepHresh™ Pro-B™) administered twice daily; a combination of Estring© and vaginal RepHresh™ Pro-B™ (twice daily); or the Estring© and oral RepHresh™ Pro-B™ (twice daily), for a duration of 30 days. …”
  17. 1997
  18. 1998
  19. 1999
  20. 2000